The effect of heparin rinse on the biocompatibility of continuous veno-venous hemodiafiltration

International Journal of Artificial Organs

Volumn 25, Issue 6, 2002, Pages 520-528

  Opatrný Jr , Karel ^a   Polanska K ^a   Krouzecky A ^a   Vit L ^a   Novak I ^a   Kasal, E ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute renal failure; Biocompatibility; Complement; Continuous renal replacement therapy; Hemostasis; Heparin rinse; Thrombogenicity

Indexed keywords

BLOOD; CHEMICAL ACTIVATION; PATIENT TREATMENT; POLYSACCHARIDES;

ACUTE RENAL FAILURE; COMPLEMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; EXTRACORPOREAL CIRCUITS; HAEMOSTASIS; HEMODIAFILTRATION; HEPARIN RINSE; RENAL FAILURE; RENAL REPLACEMENT THERAPIES; THROMBOGENICITY;

BIOCOMPATIBILITY;

ANTICOAGULANT AGENT; BETA THROMBOGLOBULIN; COMPLEMENT; COMPLEMENT COMPONENT C5A; D DIMER; HEPARIN; THROMBIN ANTITHROMBIN COMPLEX; FIBRINOLYTIC AGENT; HEMODIALYSIS FLUID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HEMOSTASIS; HUMAN; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MALE; PARTIAL THROMBOPLASTIN TIME; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOGENICITY; THROMBOSIS; BLOOD; DRUG INCOMPATIBILITY; HEMODIAFILTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AGED; COMPLEMENT ACTIVATION; CRITICAL ILLNESS; CROSS-OVER STUDIES; DRUG INCOMPATIBILITY; FEMALE; FIBRINOLYTIC AGENTS; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HEMOSTASIS; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 0035985387     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202500606     Document Type: Article

References (25)

1. Management of severe acute renal failure in critically ill patients: An international survey in 345 centres
2. A clinical study of assess the effect of heparin in dialyzer rinsing solution
3. Heparin-free dialysis following pre-rinsing of Hemophan with high doses of heparin
4. Extracorporeal therapies in acute renal failure: Different therapeutic options
5. Efficiency of hemodialysis using heparin bound Hemophan in patients at high risk bleeding
6. Biocompatibility: The need for a systems approach
7. The effect of ultrafiltered dialysate on cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis
8. Clotting in dialyzers due to low pH of dialysis fluid
9. Increased amounts of C3a and the terminal complement complex at high dialysis blood-flow: The relation with dialysis efficiency
10. Heparin-free hypothermal hemodialysis at 20°C improves biocompatibility
11. A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit
12. Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded bioline system
13. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis
14. Haemodialysis membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomised multicentre trial
15. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia
16. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis
17. Predilution versus postdilution for continuous arteriovenous hemofiltration
18. Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan
19. Hemocompatibility in hemodialysis and erythropoietin therapy
20. Modulation of complement activation on hemodialysis membranes by immobilized heparin
21. Heparin adsorption on Nephral ST: In vitro/ex vivo results
22. AN69ST dialysis membrane allows reduced standard heparin doses during dialysis
23. A clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose
24. Formation of thrombin-antithrombin III complex using polyamide and hemophan dialyzers
25. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis